OTC Pharmaceuticals: Global Industry Guide
Pages: 185
Publisher: Datamonitor
Date Published: March 2007
Format: PDF
Price: $995
Overview
Datamonitor’s OTC Pharmaceuticals Global Industry Guide is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation
- Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
- Covers Global, European, Asia-Pacific & 11 individual country markets
- Includes a five-year forecast of the industry
Highlights
The global OTC pharmaceuticals market generated total revenues of $88.7 billion in 2006, this representing a compound annual growth rate (CAGR) of 5.1% for the five-year period spanning 2002-2006.
Traditional medicines proved the most lucrative for the global OTC pharmaceuticals market in 2006, generating total revenues of $22.6 billion, equivalent to 25.5% of the market’s overall value.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 5.4% for the five-year period 2006-2011 expected to drive the market to a value of $115.4 billion by the end of 2011.
Why you should buy this report:
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indigestion preparations, medicated skin products, traditional medicines, vitamins and minerals and other OTC healthcare products at retail selling price (RSP) and includes any applicable taxes. The data in this industry profile is based on the most recent figures available at the time of publication and any currency conversions used in the creation of this report have been calculated using constant 2005 annual average exchange rates.
For the purposes of this report, Europe is deemed to consist of Belgium, the Czech Republic, Denmark, France, Germany, Hungary Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
Asia-Pacific is deemed to consist of Australia, China, India, Japan, Singapore, South Korea and Taiwan.
The Americas consists of the US, Brazil, Canada and Mexico.
The global market consists of Europe, Asia-Pacific and the Americas.
Table of Contents
CHAPTER 1 Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
CHAPTER 2 Global OTC Pharmaceuticals
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
CHAPTER 3 OTC Pharmaceuticals in Asia Pacific
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
CHAPTER 4 OTC Pharmaceuticals in Europe
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 5 OTC Pharmaceuticals in Belgium
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 6 OTC Pharmaceuticals in Canada
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 7 OTC Pharmaceuticals in China
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 8 OTC Pharmaceuticals in France
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 9 OTC Pharmaceuticals in Germany
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 10 OTC Pharmaceuticals in Italy
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 11 OTC Pharmaceuticals in Japan
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 12 OTC Pharmaceuticals in the Netherlands
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 13 OTC Pharmaceuticals in Spain
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 14 OTC Pharmaceuticals in the United Kingdom
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 15 OTC Pharmaceuticals in the United States
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Competitive Landscape
Distribution
Market Forecasts
Macroeconomic Indicators
CHAPTER 16 Company Profiles
Johnson & Johnson
Taisho Pharmaceutical Co., Ltd.
Pfizer Inc
CHAPTER 17 Appendix
Data Research Methodology
Report writing team
List of Tables
Table 1: Global OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 5: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 6: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 7: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 8: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 9: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 10: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 11: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 12: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 13: Europe OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 14: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 15: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 16: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 17: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 18: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 19: Europe Exchange Rate, 2002
Table 20: Belgium OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 21: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 22: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 23: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 24: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 25: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2006-2011
Table 26: Belgium Size of Population (million) , 2002-2006
Table 27: Belgium GDP (1995=100), 2002-2006
Table 28: Belgium Exchange Rate, 2002
Table 29: Canada OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 30: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 31: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 32: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 33: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 34: Canada OTC Pharmaceuticals Market Value Forecast: $ million, 2006-2011
Table 35: Canada Size of Population (million) , 2002-2006
Table 36: Canada GDP (1995=100), 2002-2006
Table 37: Canada Inflation, 2002-2006
Table 38: Canada Exchange Rate, 2002
Table 39: China OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 40: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 41: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 42: China OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 43: China OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 44: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 45: China Size of Population (million) , 2002-2006
Table 46: China GDP (1995=100), 2002-2006
Table 47: China Inflation, 2002-2006
Table 48: China Exchange Rate, 2002
Table 49: France OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 50: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 51: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 52: France OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 53: France OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 54: France OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 55: France Size of Population (million) , 2002-2006
Table 56: France GDP (1995=100), 2002-2006
Table 57: France Inflation, 2002-2006
Table 58: France Exchange Rate, 2002
Table 59: Germany OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 60: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 61: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 62: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 63: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 64: Germany OTC Pharmaceuticals Market Value Forecast: $ million, 2006-2011
Table 65: Germany Size of Population (million) , 2002-2006
Table 66: Germany GDP (1995=100), 2002-2006
Table 67: Germany Inflation, 2002-2006
Table 68: Germany Exchange Rate, 2002
Table 69: Italy OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 70: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 71: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 72: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 73: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 74: Italy OTC Pharmaceuticals Market Value Forecast: $ million, 2006-2011
Table 75: Italy Size of Population (million) , 2002-2006
Table 76: Italy GDP (1995=100), 2002-2006
Table 77: Italy Inflation, 2002-2006
Table 78: Italy Exchange Rate, 2002
Table 79: Japan OTC Pharmaceuticals Market Value: $ billion, 2002-2006
Table 80: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 81: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 82: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 83: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 84: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011
Table 85: Japan Size of Population (million) , 2002-2006
Table 86: Japan GDP (1995=100), 2002-2006
Table 87: Japan Exchange Rate, 2002
Table 88: Netherlands OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 89: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 90: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 91: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2004
Table 92: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2004
Table 93: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2006-2011
Table 94: Netherlands Size of Population (million) , 2002-2006
Table 95: Netherlands GDP (1995=100), 2002-2006
Table 96: Netherlands Exchange Rate, 2002
Table 97: Spain OTC Pharmaceuticals Market Value: $ million, 2002-2006
Table 98: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006
Table 99: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006
Table 100: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2004
